Recombinant Escherichia coli Probable two-component-system connector protein AriR (ariR)

Shipped with Ice Packs
In Stock

Description

Introduction to AriR

AriR (Regulator of Acid Resistance Influenced by Indole) is a gene regulatory protein encoded by the ariR gene (previously ymgB) in E. coli. It was reclassified due to its functional role in acid resistance and biofilm dynamics . AriR operates within the ymgABC gene cluster, which is transcriptionally linked to stress response pathways .

Biofilm Repression

AriR suppresses biofilm formation in glucose-rich media, contrasting with biofilm-promoting signals like AI-2 .

FunctionMechanismReference
Biofilm inhibitionRepresses gadABC and hdeABD transcription
Acid resistance modulationEnhances survival at pH ≤ 2 via chaperone systems
Motility reductionDownregulates flagellar synthesis pathways

Acid Resistance

AriR coordinates acid-stress responses by:

  • Repressing gadABC (glutamate decarboxylase system) and hdeABD (periplasmic chaperones) .

  • Counteracting indole-mediated acid sensitivity .

Regulatory Mechanisms

  • Indole Interaction: Indole upregulates ariR, creating feedback loops that modulate acid-resistance genes .

  • Cross-Talk with Two-Component Systems (TCS):

    • Although not a canonical TCS component, AriR interfaces with stress-response pathways (e.g., CpxA/CpxR) .

    • Structural homology to Hha, a DNA-binding protein, suggests shared regulatory strategies .

Key Studies

  • Biofilm-Acid Resistance Axis:

    • ariR deletion increases biofilm formation 7,000-fold while downregulating gadABCX .

    • AI-2 signaling represses gadABC 7–12-fold, linking quorum sensing to acid adaptation .

  • Structural Analysis:

    • AriR’s dimeric structure enables cooperative DNA binding, mimicking Hha’s regulatory function .

Comparative Analysis

FeatureAriRHha
Sequence Identity5%100% (self)
DNA-Binding MotifGTAAA-(N)₄–₈-GTAAAVariable
Acid ResistanceDirect repression of gadABCIndirect via nucleoid structuring

Implications and Applications

  • Biotechnology: AriR’s regulatory role could optimize recombinant protein production by decoupling stress responses from growth (e.g., phage-derived RNAP inhibitors) .

  • Pathogen Control: Targeting AriR-indole interactions may disrupt E. coli colonization in hostile environments .

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can request a specific format when ordering.
Lead Time
Delivery times vary. Consult local distributors for specifics. Proteins are shipped with blue ice packs by default; request dry ice in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ariR; ymgB; b1166; JW1153; Probable two-component-system connector protein AriR
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-88
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli (strain K12)
Target Names
ariR
Target Protein Sequence
MLEDTTIHNA ITDKALASYF RSSGNLLEEE SAVLGQAVTN LMLSGDNVNN KNIILSLIHS LETTSDILKA DVIRKTLEIV LRYTADDM
Uniprot No.

Target Background

Function
AriR likely connects RcsB/C regulation of biofilm and acid-resistance, adding input to the two-component signaling pathway. It may stimulate biofilm maturation via the Rcs phosphorelay. AriR regulates genes involved in acid-resistance and biofilm formation, including the RcsB/C system. It may be a non-specific DNA-binding protein. It also confers H₂O₂ resistance. Overexpression increases colanic acid production and reduces curli fimbriae expression, both requiring RcsB. AriR likely stimulates RcsB/C activity, not transcription. 5-fluorouracil's biofilm reduction requires AriR.
Gene References Into Functions
1. YmgB (AriR) represses biofilm formation in glucose-rich media, decreases motility, and provides acid-resistance in E. coli (PMID: 17765265) 2. 5-FU inhibits biofilm formation via AriR (PMID: 19172264)
Database Links
Protein Families
AriR family

Q&A

What is the AriR protein in Escherichia coli and what role does it play in bacterial signaling?

AriR (also known as YedV) is a probable two-component-system connector protein in Escherichia coli that functions as part of bacterial signal transduction pathways. Two-component systems typically consist of a sensor histidine kinase and a response regulator, allowing bacteria to sense and respond to environmental changes. AriR serves as a connector protein within this signaling network, facilitating communication between different regulatory components. The protein contributes to bacterial adaptation to environmental stressors and may participate in processes such as biofilm formation, antibiotic resistance mechanisms, and metabolic regulation. Understanding AriR function is particularly valuable for researchers investigating bacterial signaling networks and potential antimicrobial targets.

What expression systems are most effective for recombinant AriR production?

For recombinant AriR production, the T7 promoter-based expression system, particularly the pET expression system, is highly recommended due to its robust performance. This system can achieve protein accumulation levels of up to 50% of total cellular proteins . The pET system utilizes the T7 RNA polymerase under control of the lacUV5 promoter, which is induced by IPTG. For controlled expression, researchers can co-express T7 lysozyme, which inhibits transcription by T7 RNA polymerase, providing a tunable expression system .

Alternative promoter systems include:

  • Arabinose promoter: Offers low basal transcriptional activity but gene-dependent repression efficiency

  • Hybrid promoters (trc and tac): Demonstrate some leaky expression which may be problematic

  • Rhamnose promoter: Provides exceptionally well-titratable expression for fine control

The optimal choice depends on specific research requirements regarding basal expression levels, induction strength, and expression timing.

What are the critical factors affecting recombinant AriR solubility?

Several factors critically influence recombinant AriR solubility in E. coli expression systems:

  • Expression temperature: Lower temperatures (20°C) generally promote proper protein folding and increase solubility by slowing down translation rates and reducing inclusion body formation .

  • Induction parameters: Optimal IPTG concentration (typically around 100 μM) and dissolved oxygen levels (approximately 30%) significantly impact proper protein folding .

  • mRNA folding at 5' region: The stability of mRNA secondary structures around the ribosome binding site and within the first ~16 codons substantially influences expression efficiency and protein solubility .

  • Codon usage: Optimizing the AT-content of N-terminal codons can decrease the propensity for mRNA secondary structure formation, enhancing translation efficiency and potentially improving solubility .

  • Fusion tags: Strategic selection of solubility-enhancing fusion partners (such as thioredoxin, SUMO, or MBP) can dramatically improve AriR solubility by providing a folding nucleus and increasing hydrophilicity.

Combining these approaches—particularly lower expression temperatures with optimized induction parameters—provides the most effective strategy for producing soluble recombinant AriR protein.

How should I optimize the expression conditions for recombinant AriR protein in E. coli?

Optimizing expression conditions for recombinant AriR requires a systematic approach using statistical experimental design. Based on established methodologies for recombinant protein production, follow this optimization protocol:

  • Apply Box-Behnken statistical design: This approach allows simultaneous evaluation of multiple parameters and their interactions. Focus on three key variables: IPTG concentration, dissolved oxygen (DO) levels, and temperature .

  • Parameter ranges to test:

    • IPTG concentration: 50-500 μM

    • Dissolved oxygen: 10-50%

    • Temperature: 18-30°C

  • Establish center points: For example, 100 μM IPTG, 30% DO, and 20°C have proven effective for other recombinant proteins in E. coli .

  • Measure response variables: Quantify total protein yield, soluble fraction percentage, and biological activity.

ParameterLow LevelCenter PointHigh Level
IPTG (μM)50100500
DO (%)103050
Temperature (°C)182030

Studies with similar recombinant proteins have demonstrated that the combination of moderate IPTG concentration (100 μM), moderate DO (30%), and low temperature (20°C) typically yields the highest levels of soluble, active protein . This statistical approach provides a rational framework for optimization rather than relying on trial and error.

Which E. coli strains are most suitable for AriR expression?

Selection of an appropriate E. coli strain is crucial for successful recombinant AriR expression. Consider these strains based on specific research objectives:

  • BL21(DE3) derivatives: The foundation for most protein expression work, these strains contain T7 RNA polymerase under the control of the lacUV5 promoter, enabling strong induction with IPTG .

  • Rosetta-gami2: Particularly valuable for AriR expression as it combines features addressing two common challenges:

    • Contains tRNA genes for rare codons (AGG, AGA, AUA, CUA, CCC, and GGA), enhancing expression of proteins with non-E. coli codon bias

    • Carries mutations in thioredoxin reductase (trxB) and glutathione reductase (gor) genes, creating an oxidizing cytoplasmic environment that facilitates disulfide bond formation

  • C41(DE3) and C43(DE3): Derived from BL21(DE3), these strains contain mutations that prevent cell death associated with toxic protein expression, making them suitable if AriR expression proves toxic to the host cell.

  • Arctic Express: Engineered to co-express cold-adapted chaperonins, making them ideal for expression at lower temperatures (12-15°C) where protein folding may be improved.

For initial expression trials, Rosetta-gami2 carrying the recombinant plasmid with kanamycin resistance is recommended based on successful expression of other complex recombinant proteins .

What are the most effective vector design strategies for AriR expression?

When designing vectors for optimal AriR expression, consider these critical factors:

  • Promoter selection: The T7 promoter system offers the strongest expression, with protein accumulation reaching up to 50% of total cellular proteins . For more precise control, consider:

    • Using the pET system with T7 lysozyme co-expression to regulate transcription levels

    • Incorporating mutations in the lacUV5 promoter to lower basal transcription

    • Implementing the rhamnose promoter for exceptionally well-titratable expression

  • 5' UTR and N-terminal codon optimization:

    • Optimize the first 18 nucleotides of the coding sequence, as this region strongly influences expression

    • Increase adenine (A) content in this region, as A increases the probability of high expression while guanine (G) reduces it

    • Maximize folding energy (minimize folding stability) in the 5' coding region to enhance expression

    • Consider using rare codons rather than common codons at the 5' coding region, which can increase protein expression approximately 14-fold (median 4-fold)

  • Tag selection and placement:

    • N-terminal tags: Consider His6, MBP, or SUMO tags to enhance solubility

    • C-terminal tags: Often preferable for purification if N-terminal processing is important for protein function

    • Incorporate TEV or PreScission protease cleavage sites for tag removal

  • Vector backbone considerations:

    • Select low-copy-number plasmids for potentially toxic proteins

    • Consider co-expression of molecular chaperones on the same vector or a compatible second vector

By carefully optimizing these vector design elements, particularly the 5' coding sequence and appropriate tag selection, expression levels and solubility of recombinant AriR can be significantly improved.

How does mRNA secondary structure influence AriR expression efficiency?

mRNA secondary structure plays a crucial role in determining AriR expression efficiency, particularly in the 5' region of the transcript. Recent research demonstrates several key principles:

  • Critical influence zone: The influential mRNA-folding effects are restricted primarily to the initial ~16 codons of the coding sequence . This region is particularly important because stable secondary structures can impede ribosome binding and translation initiation.

  • Nucleotide composition effects: Within the first 18 nucleotides of the coding sequence, adenine (A) increases the probability of high expression, while guanine (G) reduces it. Cytosine (C) and uracil (U) have intermediate effects . This pattern relates to the propensity of these nucleotides to form stable secondary structures.

  • Folding energy optimization: Maximizing the folding energy (minimizing folding stability) in the 5' coding region has been shown to produce uniformly high expression levels . This approach reduces the formation of inhibitory secondary structures.

  • AT-content optimization: Increasing the AT-content of N-terminal codons decreases the propensity of the mRNA around the ribosome binding site to form secondary structures, thereby enhancing translation initiation efficiency .

For optimal AriR expression, design the coding sequence with particular attention to the 5' region, avoiding stable stem-loop structures that could interfere with ribosome binding. Computational tools can predict mRNA folding energy and help design sequences with minimal inhibitory structure formation. This rational design approach represents a significant advancement over trial-and-error methods traditionally used in recombinant protein expression.

What fusion tags and solubility enhancers are most effective for AriR purification?

Selecting appropriate fusion tags and solubility enhancers is critical for successful AriR purification. Based on extensive research with recombinant proteins in E. coli, these options offer distinct advantages:

  • Affinity tags for purification:

    • Hexahistidine (His6): Provides simple IMAC purification with minimal impact on protein structure

    • Strep-tag II: Offers highly specific binding with gentle elution conditions

    • FLAG tag: Enables ultra-high specificity purification but at higher cost

  • Solubility-enhancing fusion partners:

    • Maltose-binding protein (MBP): Substantially increases solubility while providing affinity purification capability

    • Small ubiquitin-like modifier (SUMO): Enhances solubility and can be precisely removed by SUMO protease

    • Thioredoxin (Trx): Promotes disulfide bond formation and proper folding

    • Glutathione S-transferase (GST): Provides both solubility enhancement and affinity purification

  • Cleavage considerations:

    • TEV protease: Highly specific cleavage with minimal non-specific activity

    • PreScission protease: Efficient at low temperatures, reducing degradation risk

    • Factor Xa: Leaves fewer additional amino acids after cleavage

For AriR specifically, a dual-tag approach combining an N-terminal solubility enhancer (MBP or SUMO) with a C-terminal His6 tag often proves most effective, allowing initial capture via the solubility tag followed by secondary purification after tag cleavage. When designing the construct, include a well-characterized protease cleavage site between the tag and AriR to facilitate tag removal while minimizing additional amino acids that might affect protein function.

How can I troubleshoot poor yield and solubility issues with recombinant AriR?

When encountering poor yield and solubility of recombinant AriR, implement this systematic troubleshooting approach:

  • Expression conditions optimization:

    • Reduce temperature to 15-20°C during induction to slow protein synthesis and facilitate proper folding

    • Lower IPTG concentration to 100 μM or less to reduce expression rate

    • Maintain dissolved oxygen at approximately 30% to support proper protein folding

    • Consider auto-induction media which provides gradual induction and often improves solubility

  • mRNA structure and codon usage analysis:

    • Examine the 5' coding region for stable secondary structures that might impede translation

    • Optimize the first 18 nucleotides by increasing adenine content and decreasing guanine

    • Verify codon usage compatibility with the expression host, particularly for rare codons

  • Co-expression strategies:

    • Co-express molecular chaperones (GroEL/GroES, DnaK/DnaJ/GrpE) to assist protein folding

    • Include disulfide bond isomerases (DsbA, DsbC) if AriR contains disulfide bonds

    • Consider co-expression with protein partners if AriR functions in a complex

  • Extraction and solubilization approaches:

    • Test different lysis buffers with varying pH, salt concentrations, and mild detergents

    • Include stabilizing additives such as glycerol (5-10%), arginine (50-200 mM), or specific cofactors

    • For inclusion bodies, develop a refolding protocol using gradual dialysis against decreasing concentrations of chaotropic agents

  • Construct redesign considerations:

    • Implement domain-based expression if full-length AriR proves problematic

    • Add solubility-enhancing fusion tags (MBP, SUMO, Trx) at the N-terminus

    • Remove flexible or hydrophobic regions that may promote aggregation

Systematic documentation of each intervention and its effects will help identify the most effective combination of approaches for your specific construct.

What statistical design methods should I use to optimize AriR production?

For rigorous optimization of AriR production, implement statistical experimental design methodologies instead of traditional one-factor-at-a-time approaches:

  • Box-Behnken design (BBD): Particularly effective for fermenter-scale optimization of recombinant protein production . This design:

    • Requires fewer experimental runs than a full factorial design

    • Avoids extreme condition combinations that may be impractical

    • Efficiently identifies optimal conditions and interactions between variables

  • Implementation strategy:

    • Select 3-4 key variables (e.g., temperature, IPTG concentration, dissolved oxygen, pH)

    • Establish appropriate ranges based on preliminary experiments

    • Augment the design with center points to assess process stability and experimental error

  • Response analysis:

    • Measure multiple responses: total protein yield, soluble fraction percentage, specific activity

    • Apply response surface methodology (RSM) to generate mathematical models

    • Validate optimal conditions with confirmation runs

ParameterLow Level (-1)Center Point (0)High Level (+1)
Temperature (°C)202530
IPTG (μM)50100150
Dissolved Oxygen (%)203040
pH6.87.27.6
  • Analysis tools:

    • ANOVA to determine significant factors and interactions

    • Regression analysis to develop predictive models

    • Response surface plots to visualize optimal conditions

Previous studies using this approach for recombinant fusion proteins in E. coli have identified optimal conditions at 100 μM IPTG, 30% dissolved oxygen, and 20°C temperature, which resulted in significantly improved protein yields . This statistical approach transforms optimization from an art to a science, reducing development time and resources while improving reproducibility.

How can I scale up AriR production from laboratory to pilot scale?

Scaling up AriR production from laboratory to pilot scale requires a systematic approach to ensure consistent quality and yield:

  • Process parameter translation:

    • Maintain constant oxygen transfer rate (OTR) rather than identical agitation rates

    • Scale up based on constant power input per volume (P/V) or constant impeller tip speed

    • Preserve mixing time by adjusting impeller configuration and speed

  • Feeding strategy optimization:

    • Implement fed-batch cultivation to achieve higher cell densities and protein yields

    • Develop appropriate feeding algorithms based on oxygen uptake rate (OUR) or pH-stat control

    • Consider exponential feeding to maintain specific growth rate below critical levels that cause overflow metabolism

  • Induction strategy refinement:

    • Optimize induction timing based on biomass concentration (typically at OD600 of 8-10)

    • Maintain the optimal IPTG concentration identified in laboratory scale (approximately 100 μM)

    • Consider pulse feeding of inducer for prolonged expression periods

  • Process monitoring and control:

    • Implement online monitoring of dissolved oxygen, pH, and temperature

    • Consider capacitance-based biomass monitoring for real-time growth assessment

    • Develop feed-forward control systems based on metabolic models

  • Harvest and downstream processing considerations:

    • Scale-appropriate cell harvesting method (continuous centrifugation or depth filtration)

    • Adjust lysis methods from sonication to high-pressure homogenization

    • Implement tangential flow filtration for initial concentration/diafiltration steps

For effective scale-up, start with parameters identified using Box-Behnken design in laboratory fermenters (typically 100 μM IPTG, 30% dissolved oxygen, 20°C) , then systematically adjust these parameters while maintaining critical dimensionless numbers (Reynolds, Power, and Péclet numbers) to ensure comparable mixing and mass transfer at larger scales.

What are the most effective purification strategies for recombinant AriR?

Developing an effective purification strategy for recombinant AriR requires a multi-step approach that maximizes yield while ensuring high purity and biological activity:

  • Initial capture step:

    • Immobilized Metal Affinity Chromatography (IMAC) for His-tagged AriR: Use Ni-NTA or TALON resins with imidazole gradient elution

    • Affinity chromatography for fusion-tagged AriR: MBP-tagged proteins can be purified using amylose resin, while GST-tagged proteins use glutathione-based matrices

  • Intermediate purification:

    • Ion Exchange Chromatography (IEX): Based on AriR's theoretical pI, select appropriate resin (cation exchange for proteins with pI > 7.0, anion exchange for pI < 7.0)

    • Tag removal: Apply site-specific proteases (TEV, PreScission, or SUMO protease) followed by reverse affinity chromatography to remove the cleaved tag and protease

  • Polishing steps:

    • Size Exclusion Chromatography (SEC): Separates AriR monomers from aggregates and oligomers while performing buffer exchange

    • Hydrophobic Interaction Chromatography (HIC): Particularly useful for removing endotoxins and protein contaminants with similar charge properties

  • Quality control assessments:

    • SDS-PAGE and Western blotting to confirm identity and assess purity

    • Mass spectrometry to verify protein integrity and post-translational modifications

    • Activity assays to confirm biological function

Purification StepResin/MethodBuffer CompositionExpected Recovery
IMACNi-NTA50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10-250 mM imidazole70-80%
Tag CleavageTEV Protease50 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM DTT85-95%
IEXQ-Sepharose20 mM Tris-HCl pH 8.0, 50-500 mM NaCl gradient70-80%
SECSuperdex 20020 mM Tris-HCl pH 7.5, 150 mM NaCl90-95%

For high-throughput purification in research settings, consider simplified two-step protocols combining IMAC with SEC, potentially using automated systems. For applications requiring exceptional purity, implement the full multi-step protocol with appropriate quality control at each stage.

How can I assess the structural integrity and functional activity of purified AriR?

Comprehensive assessment of purified AriR requires multiple complementary approaches to evaluate both structural integrity and functional activity:

  • Structural integrity analysis:

    • Circular Dichroism (CD) Spectroscopy: Provides information about secondary structure content (α-helices, β-sheets)

    • Differential Scanning Fluorimetry (DSF): Determines thermal stability and identifies buffer conditions that enhance protein stability

    • Size Exclusion Chromatography coupled with Multi-Angle Light Scattering (SEC-MALS): Accurately determines molecular weight and oligomeric state

    • Limited Proteolysis: Identifies flexible regions and confirms proper folding

  • Functional characterization:

    • Phosphorylation Assays: For two-component system proteins, assess auto-phosphorylation and phosphotransfer capabilities

    • Binding Studies: Use isothermal titration calorimetry (ITC) or microscale thermophoresis (MST) to measure binding affinities with response regulators or DNA targets

    • Surface Plasmon Resonance (SPR): Provides kinetic parameters (kon and koff) for interactions with partner molecules

  • Structural biology approaches:

    • X-ray Crystallography: Provides atomic-resolution structure when crystals can be obtained

    • Nuclear Magnetic Resonance (NMR): Useful for dynamic studies and structure determination of smaller domains

    • Cryo-Electron Microscopy: Particularly valuable for large protein complexes or membrane-associated forms

  • In vivo functional validation:

    • Complementation Assays: Test if purified AriR can restore function in AriR knockout strains

    • Reporter Gene Assays: Measure AriR-dependent transcriptional regulation using fluorescent or luminescent reporters

    • Bacterial Two-Hybrid Systems: Identify interaction partners and assess the impact of mutations

For comprehensive characterization, combine biophysical methods (CD, DSF) for initial quality assessment, followed by functional assays specific to two-component system proteins, and ultimately structural studies if detailed mechanistic insights are required. This multi-faceted approach ensures both structural integrity and biological activity are thoroughly validated.

What are the current limitations in AriR research and future directions?

Current research on recombinant AriR faces several significant limitations that represent opportunities for future investigation:

  • Structural characterization challenges:

    • Limited availability of high-resolution structures of full-length AriR protein

    • Incomplete understanding of conformational changes during signal transduction

    • Difficulties in capturing transient interaction states with partner proteins

  • Functional knowledge gaps:

    • Uncertainty about natural ligands or environmental signals that activate the AriR system

    • Incomplete characterization of the regulon controlled by this two-component system

    • Limited understanding of cross-talk with other signaling pathways in E. coli

  • Technical hurdles:

    • Challenges in producing consistently active recombinant protein

    • Difficulties in reconstituting complete signaling pathways in vitro

    • Limited availability of specific antibodies and detection reagents

Future research directions should focus on:

  • Developing improved expression systems specifically optimized for two-component system proteins

  • Applying integrative structural biology approaches (combining crystallography, cryo-EM, and NMR)

  • Creating synthetic biology tools to manipulate and study AriR signaling in vivo

  • Investigating the role of AriR in bacterial stress responses and potential applications in biotechnology

The field would particularly benefit from collaborative efforts that combine expertise in protein biochemistry, structural biology, and bacterial genetics to develop a comprehensive understanding of AriR function within the complex network of bacterial signal transduction.

How does recombinant AriR research contribute to broader understanding of bacterial signaling?

Research on recombinant AriR offers valuable insights that extend beyond this specific protein to enhance our broader understanding of bacterial signaling systems:

  • Model system for connector protein function:

    • AriR research provides a framework for understanding how connector proteins integrate signals across different two-component systems

    • This work helps elucidate mechanisms of signal specificity versus cross-talk in bacterial signaling networks

    • Findings can inform computational models of bacterial signaling network architecture and evolution

  • Methodological advancements:

    • Optimization strategies developed for AriR expression and purification can be applied to other challenging membrane-associated signaling proteins

    • Functional assay development for AriR provides templates for characterizing other two-component system proteins

    • Structural studies of AriR contribute to broader understanding of protein domain arrangements in signaling complexes

  • Applications in synthetic biology:

    • Understanding AriR function enables its potential use as a modular component in engineered signaling circuits

    • Knowledge of AriR regulation mechanisms informs design principles for synthetic two-component systems

    • Characterization of AriR signaling kinetics helps calibrate mathematical models of cellular decision-making

  • Antimicrobial development implications:

    • As two-component systems are absent in mammals, detailed understanding of AriR structure and function may reveal novel targets for antimicrobial development

    • Insights into signal transduction mechanisms could inform strategies to disrupt bacterial adaptation to environmental stresses

    • Conserved features identified through AriR research may apply to virulence-associated signaling systems in pathogens

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.